SecSonar.com

Evaxion Biotech A/S (EVAX)

Evaxion Biotech A/S at a glance — key fundamentals, SEC filings, insider buying and selling, and earnings dates.

Evaxion Biotech A/S (EVAX) is a Biotechnology company based in DK with a market capitalization of $25.8M. Revenue grew 125.1% year-over-year and free cash flow was negative at -$6.7M. This page tracks EVAX's SEC filings, insider buying and selling, earnings dates, and key fundamentals in one place.

DK · 46 employees · IPO Feb 5, 2021

Valuation

Valuation & price

$4.04 · as of May 26, 2026 · -63.3% vs 52w high

—

P/E ratio

Latest-FY diluted EPS

1.51

P/B ratio

Market cap ÷ book equity

—

Dividend yield

Price — last 12 months

$9.60$5.95$2.30Jul 25Dec 25Jul 26Jul 7, 25$2.30Jul 9, 25$2.54Jul 11, 25$2.66Jul 15, 25$2.54Jul 17, 25$2.65Jul 21, 25$2.57Jul 23, 25$2.68Jul 25, 25$2.72Jul 29, 25$2.94Jul 31, 25$2.68Aug 4, 25$2.72Aug 6, 25$2.83Aug 11, 25$2.77Aug 13, 25$3.04Aug 15, 25$2.88Aug 19, 25$3.04Aug 21, 25$3.10Aug 25, 25$3.21Aug 27, 25$3.03Aug 29, 25$2.75Sep 3, 25$2.59Sep 5, 25$2.92Sep 9, 25$2.80Sep 11, 25$2.88Sep 16, 25$2.94Sep 18, 25$3.02Sep 22, 25$3.05Sep 24, 25$3.30Sep 26, 25$4.04Sep 30, 25$3.76Oct 2, 25$4.74Oct 6, 25$6.95Oct 8, 25$6.29Oct 10, 25$5.90Oct 14, 25$7.84Oct 16, 25$9.60Oct 21, 25$6.53Oct 23, 25$5.61Oct 27, 25$6.13Oct 29, 25$5.75Oct 31, 25$5.75Nov 4, 25$5.60Nov 6, 25$6.26Nov 10, 25$6.38Nov 12, 25$6.04Nov 14, 25$5.46Nov 18, 25$5.26Nov 20, 25$5.34Nov 25, 25$5.40Nov 28, 25$5.94Dec 2, 25$5.12Dec 4, 25$5.29Dec 8, 25$6.28Dec 10, 25$6.37Dec 12, 25$6.21Dec 16, 25$6.09Dec 18, 25$5.75Dec 22, 25$5.13Dec 24, 25$4.92Dec 29, 25$4.91Jan 2, 26$4.71Jan 6, 26$5.05Jan 8, 26$5.11Jan 12, 26$5.18Jan 14, 26$5.06Jan 16, 26$4.55Jan 21, 26$4.18Jan 23, 26$4.04Jan 27, 26$4.01Jan 29, 26$3.40Feb 2, 26$3.10Feb 4, 26$3.13Feb 9, 26$3.47Feb 11, 26$3.31Feb 13, 26$3.34Feb 18, 26$3.32Feb 20, 26$3.29Feb 24, 26$3.47Feb 26, 26$3.25Mar 2, 26$3.17Mar 4, 26$3.11Mar 6, 26$3.22Mar 10, 26$3.58Mar 12, 26$4.18Mar 17, 26$3.83Mar 19, 26$4.00Mar 23, 26$3.88Mar 25, 26$3.70Mar 27, 26$3.52Mar 31, 26$3.72Apr 2, 26$3.78Apr 7, 26$3.80Apr 9, 26$4.11Apr 13, 26$4.14Apr 15, 26$4.14Apr 17, 26$4.45Apr 22, 26$4.27Apr 24, 26$4.03Apr 28, 26$4.32Apr 30, 26$4.41May 4, 26$4.57May 6, 26$4.41May 8, 26$4.34May 12, 26$4.17May 14, 26$4.12May 18, 26$4.09May 20, 26$4.00May 22, 26$4.08May 28, 26$4.10Jun 1, 26$3.90Jun 3, 26$3.54Jun 5, 26$3.55Jun 9, 26$3.63Jun 11, 26$3.61Jun 15, 26$3.60Jun 17, 26$3.32Jun 22, 26$3.42Jun 24, 26$3.38Jun 26, 26$3.09Jul 2, 26$3.41
$2.3052-week range$11.01
Loading valuation history…

Fundamentals

Key fundamentals

$25.8M

Market cap

125.1%

Revenue growth (YoY)

100.0%

Gross margin

-$6.7M

Free cash flow (USD)

-$15.7M

Net debt

Net cash position

497.3%

Share dilution

1/5

Graham criteria passed

Defensive-investor screen

Healthcare

Sector

Trajectory

Long-term trends

Revenue by year

2018 → 2025

FY 2018$0.00FY 2019$0.00FY 2020$0.00FY 2021$0.00FY 2022$0.00FY 2023$73.0KFY 2024$3.3MFY 2025$7.5M
$0$7.5M

Free cash flow by year

2018 → 2025

FY 2018$-2.0MFY 2019$-7.1MFY 2020$-12.8MFY 2021$-23.3MFY 2022$-26.1MFY 2023$-17.8MFY 2024$-12.9MFY 2025$-6.7M
-$2M-$6.7M

Gross margin by year

2023 → 2025

FY 2023100.0%FY 2024100.0%FY 2025100.0%
100.0%100.0%

Value screen

Graham defensive-investor tests

Computing the scorecard — refreshing any stale inputs…

0

Insider buys · 90 days

0

Insider sells · 90 days

Earnings

Last report: 6-K filed May 7, 2026

Next expected: not yet scheduled

On the tape

Recent SEC & insider activity

  • 6-K filingPress ReleaseJul 1, 2026Filing
  • 6-K filingAward ReceivedJun 12, 2026Filing
  • 6-K filingPreclinical Data PresentationJun 11, 2026Filing
  • 6-K filingData Presentation AnnouncementMay 12, 2026Filing
  • Annual reportAnnual Report FiledMay 7, 2026Filing
  • Annual reportAnnual Report FiledMay 4, 2026Filing
  • 6-K filingManagement ChangeApr 27, 2026Filing
  • Annual reportAnnual Report FiledApr 22, 2026Filing
  • 6-K filingPress ReleaseApr 17, 2026Filing
  • 6-K filingPress ReleaseApr 17, 2026Filing

Questions

Frequently asked questions

What is Evaxion Biotech A/S's market cap?

Evaxion Biotech A/S (EVAX) has a market capitalization of $25.8M.

What is EVAX's P/E ratio?

A meaningful P/E ratio is not available for EVAX — the company's latest fiscal-year earnings per share is zero, negative, or not yet cached.

What is EVAX's price-to-book (P/B) ratio?

EVAX trades at 1.51 times book value per share.

Are insiders buying EVAX stock?

SEC Form 4 filings show no open-market insider buys at Evaxion Biotech A/S in the last 90 days (0 sells).

Same arena

Related companies in Biotechnology

ALLR

Allarity Therapeutics, Inc.

$26M

SNTI

Senti Biosciences, Inc.

$25.5M

DYAI

Dyadic International, Inc.

$27.9M

BRNS

Barinthus Biotherapeutics plc

$27.9M

CELU

Celularity Inc.

$23.6M

IGC

IGC Pharma, Inc.

$28.7M

Timeline

Every filing, insider trade & earnings on a price-anchored timeline

Filing Analyzer

Search the actual 10-K / 10-Q text with AI research angles

News

Latest press coverage in one feed

Data: SEC EDGAR filings and cached fundamental data; prices and ratios use the most recent cached quote and statements (may lag by up to a day). Educational and research purposes only. Not investment advice.